SCYB.V - Scythian Biosciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD

Scythian Biosciences Corp.

366 Bay Street
Suite 200
Toronto, ON M5H 4B2

Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Rob ReidCEO & DirectorN/AN/AN/A
Mr. Jonathan James HeldChief Financial OfficerN/AN/A1986
Mr. Maghsoud DarianiChief Scientific OfficerN/AN/A1953
Prof. Michael BarnesChief Medical OfficerN/AN/AN/A
Mr. Gabriel MenesesVP of Latin America & CaribbeanN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.


Scythian Biosciences Corp. engages in the research and development of cannabinoid-based combination drug therapies for the treatment of concussions and traumatic brain injury. It also develops drug candidates for the treatment of gastro-intestinal inflammatory issues. The company is headquartered in Toronto, Canada.

Corporate Governance

Scythian Biosciences Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.